|
they believe, based on their observations, that EDTA is useful for that purpose.
Proponents of EDTA for vascular diseases have two principal theories for how the drug may operate in the circulatory system. One is by reducing “free radicals.” The presence of heavy metals in the blood stream can cause as increased production of free radicals and EDTA is approved by FDA to remove heavy metals that have accumulated in the body in excessive amounts.
Another theory is that EDTA binds with calcium in the blood stream and creates a series of actions that result in altering the intercellular balance of calcium with magnesium. Some scientists, however, dispute whether these changes have a positive effect on vascular disease.
Despite the lack of controlled scientific studies as proof of its effectiveness, physicians have used EDTA Chelation Therapy for over fifty years to treat such related diseases as cardiovascular disease, diabetic arterial disease, decreased mental functioning from vascular disease and intermittent claudication (leg pain ). Many of these doctors, including Dr. Barnes, also use EDTA in preventive medicine in other words by removing heavy metals and toxins from the cells, the cells have improved functioning and degenerative problems may not occur.
This therapy involves the intravenous infusions of EDTA over a course of treatments in a doctor’s office. Under current treatment protocols, EDTA Chelation therapy is safe and relatively free of side effects. Chelation therapy patients are advised to take a comprehensive approach to their treatment and health, including, as needed, diet, exercise, stress management programs and dietary supplements.
Doctors using EDTA Chelation therapy may recommend it in place of or in conjunction with other approaches for treating vascular diseases including other drug therapies, angioplasty and coronary artery by-pass grafting. A doctor who administers EDTA Chelation therapy will take into consideration individual health issues to determine which approach may be appropriate and whether surgery may be indicted.
Scientific studies on Chelation Therapy are ongoing and debate among medical professionals will continue. There is also serious controversy about the relative risks and long-term benefits of coronary bypass surgery. Because it has a favorable safety and side effect profile and does not preclude the concurrent or subsequent use of other treatments, doctors who belong to ACAM (American College for Advancement in Medicine) believe that Chelation therapy is worthy of consideration by those suffering from vascular disease.
The American College for Advancement in Medicine (ACAM) is a not-for-profit association dedicated to educating physicians and other health care professionals on the latest findings and emerging procedures in complementary, alternative and integrative (CAIM) medicine. ACAM is the voice of integrative medicine; our goals are to improve physician skills, knowledge and diagnostic procedures as they relate to complementary and alternative medicine; to support integrative medicine research; and to develop awareness of alternative methods of medical treatment.
Celebrating more than a quarter century of service, ACAM represents more than 1,000 physicians in 30 countries. ACAM is the largest and oldest organization of its kind in the world dedicated exclusively to serving the needs of the integrative medicine industry.
|
